Rescreening of Subjects. Rescreening of subjects is not allowed in this study.
Rescreening of Subjects. Subjects must be screened according to the full list of inclusion/exclusion criteria in Section 8.1 and 8.2 of this protocol. After informed consent is signed, a separate screening visit is allowed for the following criteria: INC01 – Subject must be 18 to 35 years of age EXC12 – Participation of the subject in a clinical trial within the previous 30 days or currently enrolled in any clinical trial This separate screening visit can take place regardless of whether any other criterion has been verified. Rescreening of subjects is not allowed in this study.